Amneal Pharmaceuticals, Current Valuation vs. Shares Outstanding
| AMRX Stock | USD 7.83 0.09 1.14% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.47 | 0.3428 |
|
|
For Amneal Pharmaceuticals, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Amneal Pharmaceuticals, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Amneal Pharmaceuticals, Class utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Amneal Pharmaceuticals,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Amneal Pharmaceuticals, Class over time as well as its relative position and ranking within its peers.
Amneal |
Amneal Pharmaceuticals,'s Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amneal Pharmaceuticals,. If investors know Amneal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amneal Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.75) | Earnings Share (0.86) | Revenue Per Share 9.16 | Quarterly Revenue Growth 0.133 | Return On Assets 0.0594 |
The market value of Amneal Pharmaceuticals, is measured differently than its book value, which is the value of Amneal that is recorded on the company's balance sheet. Investors also form their own opinion of Amneal Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Amneal Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amneal Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Amneal Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amneal Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Amneal Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amneal Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Amneal Pharmaceuticals, Shares Outstanding vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Amneal Pharmaceuticals,'s current stock value. Our valuation model uses many indicators to compare Amneal Pharmaceuticals, value to that of its competitors to determine the firm's financial worth. Amneal Pharmaceuticals, Class is rated third in current valuation category among its peers. It is number one stock in shares outstanding category among its peers creating about 0.06 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Amneal Pharmaceuticals, Class is roughly 16.13 . Common Stock Shares Outstanding is likely to drop to about 151.5 M in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amneal Pharmaceuticals,'s earnings, one of the primary drivers of an investment's value.Amneal Pharmaceuticals,'s Earnings Breakdown by Geography
Amneal Current Valuation vs. Competition
Amneal Pharmaceuticals, Class is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 42.34 Billion. Amneal Pharmaceuticals, retains roughly 5 Billion in current valuation claiming about 12% of equities under Health Care industry.
Amneal Shares Outstanding vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Amneal Pharmaceuticals, |
| = | 5 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Amneal Pharmaceuticals, |
| = | 309.84 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Amneal Shares Outstanding Comparison
Amneal Pharmaceuticals, is currently under evaluation in shares outstanding category among its peers.
Amneal Pharmaceuticals, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Amneal Pharmaceuticals,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Amneal Pharmaceuticals, will eventually generate negative long term returns. The profitability progress is the general direction of Amneal Pharmaceuticals,'s change in net profit over the period of time. It can combine multiple indicators of Amneal Pharmaceuticals,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -32.3 M | -30.7 M | |
| Operating Income | 204.4 M | 122.7 M | |
| Net Loss | -48.7 M | -46.3 M | |
| Income Before Tax | -40.3 M | -38.3 M | |
| Total Other Income Expense Net | -244.6 M | -232.4 M | |
| Net Loss | -117 M | -111.1 M | |
| Net Loss | -48.7 M | -46.3 M | |
| Income Tax Expense | 8.5 M | 8 M | |
| Interest Income | 199.1 M | 103.3 M | |
| Net Interest Income | -251.4 M | -238.9 M | |
| Non Operating Income Net Other | 4.7 M | 4.4 M | |
| Change To Netincome | 151.9 M | 170.7 M | |
| Net Loss | (0.48) | (0.50) | |
| Income Quality | (7.09) | (6.74) | |
| Net Income Per E B T | 2.09 | 2.19 |
Amneal Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Amneal Pharmaceuticals,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Amneal Pharmaceuticals, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Amneal Pharmaceuticals,'s important profitability drivers and their relationship over time.
Use Amneal Pharmaceuticals, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amneal Pharmaceuticals, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amneal Pharmaceuticals, will appreciate offsetting losses from the drop in the long position's value.Amneal Pharmaceuticals, Pair Trading
Amneal Pharmaceuticals, Class Pair Trading Analysis
The ability to find closely correlated positions to Amneal Pharmaceuticals, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amneal Pharmaceuticals, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amneal Pharmaceuticals, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amneal Pharmaceuticals, Class to buy it.
The correlation of Amneal Pharmaceuticals, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amneal Pharmaceuticals, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amneal Pharmaceuticals, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amneal Pharmaceuticals, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Amneal Pharmaceuticals, position
In addition to having Amneal Pharmaceuticals, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.